OTC Drug Market in India 2014

  • Product Code:
    RP-ID-10080289
  • Published Date:
    21 Oct 2022
  • Region:
    Global
  • Pages:
    85
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Pub-ID-13

Impact Analysis on the Growth of Market

Inflation and Looming Recession to Haunt Businesses:

In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.

..

..

The Research Report is Updated with 2022 Base Year, 2023 Estimated year and Forecast till 2035 with Market Insights.


With the dip in global production, the GDP has contracted in 2020 and impacted the market across the world. Upon placing a Sample Request, you will receive an updated report with 2022 as base year, 2023 as estimated year and forecast to 2035. This will have market drivers, recovery rate in the market, insights and competitive analysis.



Market Overview:

Translate Report

Netscribes' latest market research report titled OTC Drug Market in India 2014 highlights the analysis of the drivers and explains the factors for growth of the industry. Increasing self-medicated patient population, growing confidence in OTC drugs, and change of prescription drugs to OTC drugs are the key drivers of this market. The various segments of OTC drugs such as Vitamins & Minerals, Gastrointestinal, and Cough Cold & Allergy etc. are the major reasons for the popularity of the OTC drug market.

Growing number of self-treatment patient base and their confidence in the OTC drugs is helping the Indian market to grow. Prescription drugs, after becoming OTC, present a huge opportunity for growth. OTC drugs increase the availability of different types of drugs intended for self-medication among patients, which helps in the growth of the market. The increasing disposable income of people is also helping to boost the market size. Some challenges faced by the industry are the internal competition between large pharmaceutical companies. Another challenge is the penetration of OTC drugs in rural areas which is very low. Various government initiatives have been undertaken to reduce the drug prices and various tax reforms and control programs are promoting the growth of the market as well.


Geography Analysis:


The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:

  • North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys  & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
  • Middle East and Africa  (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook

.

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report
Public Companies
1. Amrutanjan Healthcare Ltd.
2. Cipla Ltd.
3. Dr. Reddy's Laboratories Ltd.
4. GlaxoSmithKline Pharmaceuticals Ltd.
5. Lupin Ltd.
6. Novartis India Ltd.
7. Pfizer Ltd.
8. P& G
9. Ranbaxy Laboratories Ltd.
10. Merck Ltd Sun Pharmaceutical Industries Ltd..
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports

-->